From Cureus.com

The study is called:

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan

During the COVID-19 pandemic, excess deaths including cancer have become a concern in Japan, which has a rapidly aging population. Thus, this study aimed to evaluate how age-adjusted mortality rates (AMRs) for different types of cancer in Japan changed during the COVID-19 pandemic (2020-2022).

Introduction

The COVID-19 pandemic began in December 2019 in Wuhan, China, and was first detected in Japan in January 2020. In response, a range of healthcare and socio-economic restrictions were implemented to curb the spread of the disease. Since February 2021, the mRNA-lipid nanoparticle (mRNA-LNP) vaccine has been available for emergency use and is recommended for all individuals aged six months and older, especially those at high risk.

As of March 2023, 80% of the Japanese population had received their first and second doses, 68% had received their third dose, and 45% had received their fourth dose [1]. Despite these national measures, 33.8 million people had been infected, and 74,500 deaths had been attributed to COVID-19 in Japan by the end of April 2023.

Additionally, excess deaths from causes other than COVID-19 have been reported in various countries [2-6], including deaths from cancer [7-10], and Japan is no exception [11,12]. Cancer is the leading cause of death in Japan, accounting for one-fourth of all deaths. Therefore, it is essential to understand the effects of the pandemic on mortality rates of cancer from 2020 to 2022. Age adjustment is necessary for accurate evaluation, especially in diseases such as cancer that tend to occur in elderly adults.

Japan has several characteristics that make it ideal for analyzing the impact of the pandemic on cancer mortality rates, including its large population of 123 million, availability of official statistics, and the high 80% accuracy rate of death certificates according to autopsy studies [13].

Conclusions

Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine. These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination rather than COVID-19 infection itself or reduced cancer care due to the lockdown. The significance of this possibility warrants further studies.

From the YouTube channel of Dr John Campbell

The numbers for 2023 are rolling in and they show a disturbing trend in most of the wealthy nations in the world.  In Canada, the United States, and virtually every country in Western Europe, the excess rate of death is astounding and so far unexplained by officials in any nation.

British health researcher Dr. John Campbell shares official data from the OECD (Organization for Economic Co-operation and Development) and wonders why the media doesn’t seem to notice or care.

From the Youtube channel of Dr. John Campbell.

Confirmation of excess deaths in 2023 for US, UK, Canada, Australia, NZ, Netherlands, and Denmark. However, deaths are lower than expected in Poland, Hungary, and Sweden.

OECD data https://stats.oecd.org/index.aspx?que…